Triclabendazole - Novartis
At a glance
- Drug Originator Novartis
- Drug Class Anthelmintics; Benzimidazoles; Chlorinated hydrocarbons; Small molecules
- Mechanism of Action Tubulin inhibitors
- USA Patent Applicants NOVARTIS
- NDAs 1
- Patent Applications 1,384
Table of Contents
Disclaimer